nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—ABCB1—colon cancer	0.381	1	CbGaD
Mefloquine—ACHE—Irinotecan—colon cancer	0.183	0.467	CbGbCtD
Mefloquine—BCHE—Irinotecan—colon cancer	0.11	0.281	CbGbCtD
Mefloquine—ABCB1—Irinotecan—colon cancer	0.0279	0.0714	CbGbCtD
Mefloquine—ABCB1—Vincristine—colon cancer	0.0244	0.0624	CbGbCtD
Mefloquine—CYP3A4—Irinotecan—colon cancer	0.0167	0.0428	CbGbCtD
Mefloquine—ABCB1—Methotrexate—colon cancer	0.0148	0.0378	CbGbCtD
Mefloquine—CYP3A4—Vincristine—colon cancer	0.0146	0.0374	CbGbCtD
Mefloquine—HBA2—endothelium—colon cancer	0.00933	0.098	CbGeAlD
Mefloquine—HBA2—blood vessel—colon cancer	0.00861	0.0904	CbGeAlD
Mefloquine—HBA2—gall bladder—colon cancer	0.0081	0.0851	CbGeAlD
Mefloquine—HBA2—embryo—colon cancer	0.00513	0.0539	CbGeAlD
Mefloquine—HBA1—renal system—colon cancer	0.00423	0.0445	CbGeAlD
Mefloquine—HBA2—epithelium—colon cancer	0.00419	0.044	CbGeAlD
Mefloquine—HBA2—smooth muscle tissue—colon cancer	0.00404	0.0424	CbGeAlD
Mefloquine—HBA2—renal system—colon cancer	0.00389	0.0408	CbGeAlD
Mefloquine—HBA1—lymphoid tissue—colon cancer	0.00351	0.0369	CbGeAlD
Mefloquine—HBA1—digestive system—colon cancer	0.00347	0.0365	CbGeAlD
Mefloquine—HBA2—lymphoid tissue—colon cancer	0.00323	0.0339	CbGeAlD
Mefloquine—HBA1—bone marrow—colon cancer	0.0032	0.0336	CbGeAlD
Mefloquine—HBA2—digestive system—colon cancer	0.00319	0.0335	CbGeAlD
Mefloquine—HBA2—bone marrow—colon cancer	0.00294	0.0309	CbGeAlD
Mefloquine—HBA1—liver—colon cancer	0.00259	0.0272	CbGeAlD
Mefloquine—HBA2—liver—colon cancer	0.00237	0.0249	CbGeAlD
Mefloquine—HBA1—lymph node—colon cancer	0.00198	0.0208	CbGeAlD
Mefloquine—HBA2—lymph node—colon cancer	0.00182	0.0191	CbGeAlD
Mefloquine—ADORA1—renal system—colon cancer	0.00175	0.0183	CbGeAlD
Mefloquine—ADORA2A—lymphoid tissue—colon cancer	0.00168	0.0176	CbGeAlD
Mefloquine—ADORA1—vagina—colon cancer	0.00126	0.0133	CbGeAlD
Mefloquine—ADORA2A—liver—colon cancer	0.00124	0.013	CbGeAlD
Mefloquine—ABCB1—blood vessel—colon cancer	0.0009	0.00946	CbGeAlD
Mefloquine—BCHE—smooth muscle tissue—colon cancer	0.000886	0.00931	CbGeAlD
Mefloquine—ADORA1—lymph node—colon cancer	0.000818	0.0086	CbGeAlD
Mefloquine—ACHE—lymph node—colon cancer	0.000813	0.00854	CbGeAlD
Mefloquine—CYP19A1—liver—colon cancer	0.000724	0.0076	CbGeAlD
Mefloquine—BCHE—digestive system—colon cancer	0.0007	0.00735	CbGeAlD
Mefloquine—BCHE—bone marrow—colon cancer	0.000645	0.00678	CbGeAlD
Mefloquine—BCHE—vagina—colon cancer	0.000618	0.00649	CbGeAlD
Mefloquine—CYP3A4—renal system—colon cancer	0.000574	0.00603	CbGeAlD
Mefloquine—CYP2D6—renal system—colon cancer	0.000565	0.00594	CbGeAlD
Mefloquine—CYP19A1—lymph node—colon cancer	0.000555	0.00583	CbGeAlD
Mefloquine—ABCB1—embryo—colon cancer	0.000537	0.00564	CbGeAlD
Mefloquine—BCHE—liver—colon cancer	0.000521	0.00548	CbGeAlD
Mefloquine—CYP3A4—digestive system—colon cancer	0.000471	0.00495	CbGeAlD
Mefloquine—CYP2D6—digestive system—colon cancer	0.000464	0.00487	CbGeAlD
Mefloquine—ABCB1—epithelium—colon cancer	0.000438	0.0046	CbGeAlD
Mefloquine—Mediastinal disorder—Vincristine—colon cancer	0.000435	0.00362	CcSEcCtD
Mefloquine—Irritability—Capecitabine—colon cancer	0.000434	0.00361	CcSEcCtD
Mefloquine—Mood swings—Capecitabine—colon cancer	0.000431	0.00359	CcSEcCtD
Mefloquine—Ataxia—Capecitabine—colon cancer	0.000428	0.00356	CcSEcCtD
Mefloquine—Alopecia—Vincristine—colon cancer	0.000427	0.00355	CcSEcCtD
Mefloquine—Angiopathy—Irinotecan—colon cancer	0.000427	0.00355	CcSEcCtD
Mefloquine—Coma—Methotrexate—colon cancer	0.000426	0.00355	CcSEcCtD
Mefloquine—Mediastinal disorder—Irinotecan—colon cancer	0.000424	0.00353	CcSEcCtD
Mefloquine—Mental disorder—Vincristine—colon cancer	0.000423	0.00352	CcSEcCtD
Mefloquine—Chills—Irinotecan—colon cancer	0.000422	0.00351	CcSEcCtD
Mefloquine—Alopecia—Irinotecan—colon cancer	0.000416	0.00346	CcSEcCtD
Mefloquine—ABCB1—renal system—colon cancer	0.000407	0.00427	CbGeAlD
Mefloquine—Muscular weakness—Capecitabine—colon cancer	0.000401	0.00334	CcSEcCtD
Mefloquine—BCHE—lymph node—colon cancer	0.0004	0.0042	CbGeAlD
Mefloquine—Alopecia—Fluorouracil—colon cancer	0.000398	0.00331	CcSEcCtD
Mefloquine—Muscle spasms—Irinotecan—colon cancer	0.000394	0.00328	CcSEcCtD
Mefloquine—Erythema—Fluorouracil—colon cancer	0.000392	0.00326	CcSEcCtD
Mefloquine—Agitation—Vincristine—colon cancer	0.000386	0.00322	CcSEcCtD
Mefloquine—Ill-defined disorder—Irinotecan—colon cancer	0.00038	0.00316	CcSEcCtD
Mefloquine—Vertigo—Vincristine—colon cancer	0.000378	0.00314	CcSEcCtD
Mefloquine—Hepatic failure—Methotrexate—colon cancer	0.000377	0.00314	CcSEcCtD
Mefloquine—Leukopenia—Vincristine—colon cancer	0.000376	0.00313	CcSEcCtD
Mefloquine—Vision blurred—Fluorouracil—colon cancer	0.000369	0.00308	CcSEcCtD
Mefloquine—Malaise—Irinotecan—colon cancer	0.000369	0.00307	CcSEcCtD
Mefloquine—Vertigo—Irinotecan—colon cancer	0.000368	0.00306	CcSEcCtD
Mefloquine—Syncope—Irinotecan—colon cancer	0.000367	0.00306	CcSEcCtD
Mefloquine—Leukopenia—Irinotecan—colon cancer	0.000366	0.00305	CcSEcCtD
Mefloquine—Convulsion—Vincristine—colon cancer	0.000364	0.00303	CcSEcCtD
Mefloquine—Hypertension—Vincristine—colon cancer	0.000363	0.00302	CcSEcCtD
Mefloquine—Loss of consciousness—Irinotecan—colon cancer	0.00036	0.00299	CcSEcCtD
Mefloquine—Myalgia—Vincristine—colon cancer	0.000358	0.00298	CcSEcCtD
Mefloquine—Visual disturbance—Methotrexate—colon cancer	0.000357	0.00297	CcSEcCtD
Mefloquine—Hypertension—Irinotecan—colon cancer	0.000353	0.00294	CcSEcCtD
Mefloquine—Pneumonia—Capecitabine—colon cancer	0.000353	0.00294	CcSEcCtD
Mefloquine—CYP3A4—liver—colon cancer	0.000351	0.00369	CbGeAlD
Mefloquine—Leukopenia—Fluorouracil—colon cancer	0.000351	0.00292	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000348	0.00289	CcSEcCtD
Mefloquine—CYP2D6—liver—colon cancer	0.000345	0.00363	CbGeAlD
Mefloquine—Renal failure—Capecitabine—colon cancer	0.000345	0.00287	CcSEcCtD
Mefloquine—Discomfort—Irinotecan—colon cancer	0.000344	0.00287	CcSEcCtD
Mefloquine—Neuropathy peripheral—Capecitabine—colon cancer	0.000344	0.00286	CcSEcCtD
Mefloquine—Anaphylactic shock—Vincristine—colon cancer	0.000343	0.00286	CcSEcCtD
Mefloquine—Oedema—Vincristine—colon cancer	0.000343	0.00286	CcSEcCtD
Mefloquine—Convulsion—Fluorouracil—colon cancer	0.00034	0.00283	CcSEcCtD
Mefloquine—ABCB1—lymphoid tissue—colon cancer	0.000338	0.00355	CbGeAlD
Mefloquine—Confusional state—Irinotecan—colon cancer	0.000337	0.0028	CcSEcCtD
Mefloquine—Nervous system disorder—Vincristine—colon cancer	0.000336	0.0028	CcSEcCtD
Mefloquine—Thrombocytopenia—Vincristine—colon cancer	0.000336	0.0028	CcSEcCtD
Mefloquine—Oedema—Irinotecan—colon cancer	0.000334	0.00278	CcSEcCtD
Mefloquine—Anaphylactic shock—Irinotecan—colon cancer	0.000334	0.00278	CcSEcCtD
Mefloquine—Myalgia—Fluorouracil—colon cancer	0.000334	0.00278	CcSEcCtD
Mefloquine—Chest pain—Fluorouracil—colon cancer	0.000334	0.00278	CcSEcCtD
Mefloquine—ABCB1—digestive system—colon cancer	0.000333	0.0035	CbGeAlD
Mefloquine—Hyperhidrosis—Vincristine—colon cancer	0.000332	0.00276	CcSEcCtD
Mefloquine—Hepatobiliary disease—Capecitabine—colon cancer	0.000332	0.00276	CcSEcCtD
Mefloquine—Discomfort—Fluorouracil—colon cancer	0.00033	0.00275	CcSEcCtD
Mefloquine—Shock—Irinotecan—colon cancer	0.000329	0.00274	CcSEcCtD
Mefloquine—Nervous system disorder—Irinotecan—colon cancer	0.000328	0.00273	CcSEcCtD
Mefloquine—Agranulocytosis—Capecitabine—colon cancer	0.000327	0.00272	CcSEcCtD
Mefloquine—Thrombocytopenia—Irinotecan—colon cancer	0.000327	0.00272	CcSEcCtD
Mefloquine—Irritability—Methotrexate—colon cancer	0.000323	0.00269	CcSEcCtD
Mefloquine—Hyperhidrosis—Irinotecan—colon cancer	0.000323	0.00269	CcSEcCtD
Mefloquine—Confusional state—Fluorouracil—colon cancer	0.000323	0.00269	CcSEcCtD
Mefloquine—Mood swings—Methotrexate—colon cancer	0.000321	0.00267	CcSEcCtD
Mefloquine—Hypotension—Vincristine—colon cancer	0.000321	0.00267	CcSEcCtD
Mefloquine—Bradycardia—Capecitabine—colon cancer	0.00032	0.00267	CcSEcCtD
Mefloquine—Anaphylactic shock—Fluorouracil—colon cancer	0.00032	0.00266	CcSEcCtD
Mefloquine—Oedema—Fluorouracil—colon cancer	0.00032	0.00266	CcSEcCtD
Mefloquine—Ataxia—Methotrexate—colon cancer	0.000318	0.00265	CcSEcCtD
Mefloquine—Nervous system disorder—Fluorouracil—colon cancer	0.000314	0.00261	CcSEcCtD
Mefloquine—Thrombocytopenia—Fluorouracil—colon cancer	0.000313	0.00261	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000313	0.0026	CcSEcCtD
Mefloquine—Tachycardia—Fluorouracil—colon cancer	0.000312	0.0026	CcSEcCtD
Mefloquine—Hypotension—Irinotecan—colon cancer	0.000312	0.0026	CcSEcCtD
Mefloquine—Insomnia—Vincristine—colon cancer	0.00031	0.00258	CcSEcCtD
Mefloquine—Connective tissue disorder—Capecitabine—colon cancer	0.000309	0.00257	CcSEcCtD
Mefloquine—Paraesthesia—Vincristine—colon cancer	0.000308	0.00256	CcSEcCtD
Mefloquine—ABCB1—bone marrow—colon cancer	0.000307	0.00323	CbGeAlD
Mefloquine—Visual impairment—Capecitabine—colon cancer	0.000303	0.00252	CcSEcCtD
Mefloquine—Insomnia—Irinotecan—colon cancer	0.000302	0.00252	CcSEcCtD
Mefloquine—Paraesthesia—Irinotecan—colon cancer	0.0003	0.0025	CcSEcCtD
Mefloquine—Hypotension—Fluorouracil—colon cancer	0.000299	0.00249	CcSEcCtD
Mefloquine—Decreased appetite—Vincristine—colon cancer	0.000298	0.00248	CcSEcCtD
Mefloquine—Dyspnoea—Irinotecan—colon cancer	0.000298	0.00248	CcSEcCtD
Mefloquine—Erythema multiforme—Capecitabine—colon cancer	0.000298	0.00248	CcSEcCtD
Mefloquine—Somnolence—Irinotecan—colon cancer	0.000297	0.00247	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Vincristine—colon cancer	0.000296	0.00247	CcSEcCtD
Mefloquine—Fatigue—Vincristine—colon cancer	0.000296	0.00246	CcSEcCtD
Mefloquine—ABCB1—vagina—colon cancer	0.000294	0.00309	CbGeAlD
Mefloquine—Eye disorder—Capecitabine—colon cancer	0.000294	0.00245	CcSEcCtD
Mefloquine—Dyspepsia—Irinotecan—colon cancer	0.000294	0.00245	CcSEcCtD
Mefloquine—Tinnitus—Capecitabine—colon cancer	0.000293	0.00244	CcSEcCtD
Mefloquine—Flushing—Capecitabine—colon cancer	0.000292	0.00243	CcSEcCtD
Mefloquine—Cardiac disorder—Capecitabine—colon cancer	0.000292	0.00243	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000291	0.00243	CcSEcCtD
Mefloquine—Decreased appetite—Irinotecan—colon cancer	0.00029	0.00242	CcSEcCtD
Mefloquine—Insomnia—Fluorouracil—colon cancer	0.000289	0.00241	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000288	0.0024	CcSEcCtD
Mefloquine—Fatigue—Irinotecan—colon cancer	0.000288	0.0024	CcSEcCtD
Mefloquine—Paraesthesia—Fluorouracil—colon cancer	0.000287	0.00239	CcSEcCtD
Mefloquine—Angiopathy—Capecitabine—colon cancer	0.000286	0.00238	CcSEcCtD
Mefloquine—Dyspnoea—Fluorouracil—colon cancer	0.000285	0.00237	CcSEcCtD
Mefloquine—Somnolence—Fluorouracil—colon cancer	0.000284	0.00237	CcSEcCtD
Mefloquine—Mediastinal disorder—Capecitabine—colon cancer	0.000284	0.00236	CcSEcCtD
Mefloquine—Chills—Capecitabine—colon cancer	0.000282	0.00235	CcSEcCtD
Mefloquine—Dyspepsia—Fluorouracil—colon cancer	0.000282	0.00234	CcSEcCtD
Mefloquine—Gastrointestinal pain—Vincristine—colon cancer	0.00028	0.00234	CcSEcCtD
Mefloquine—Decreased appetite—Fluorouracil—colon cancer	0.000278	0.00232	CcSEcCtD
Mefloquine—Alopecia—Capecitabine—colon cancer	0.000278	0.00232	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000276	0.0023	CcSEcCtD
Mefloquine—Mental disorder—Capecitabine—colon cancer	0.000276	0.0023	CcSEcCtD
Mefloquine—Feeling abnormal—Irinotecan—colon cancer	0.000275	0.00229	CcSEcCtD
Mefloquine—Erythema—Capecitabine—colon cancer	0.000274	0.00228	CcSEcCtD
Mefloquine—Malnutrition—Capecitabine—colon cancer	0.000274	0.00228	CcSEcCtD
Mefloquine—Gastrointestinal pain—Irinotecan—colon cancer	0.000273	0.00227	CcSEcCtD
Mefloquine—Abdominal pain—Vincristine—colon cancer	0.000271	0.00226	CcSEcCtD
Mefloquine—Body temperature increased—Vincristine—colon cancer	0.000271	0.00226	CcSEcCtD
Mefloquine—Body temperature increased—Irinotecan—colon cancer	0.000264	0.0022	CcSEcCtD
Mefloquine—Abdominal pain—Irinotecan—colon cancer	0.000264	0.0022	CcSEcCtD
Mefloquine—Feeling abnormal—Fluorouracil—colon cancer	0.000264	0.00219	CcSEcCtD
Mefloquine—Muscle spasms—Capecitabine—colon cancer	0.000263	0.00219	CcSEcCtD
Mefloquine—Pneumonia—Methotrexate—colon cancer	0.000262	0.00219	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000259	0.00215	CcSEcCtD
Mefloquine—Vision blurred—Capecitabine—colon cancer	0.000258	0.00215	CcSEcCtD
Mefloquine—Tremor—Capecitabine—colon cancer	0.000257	0.00214	CcSEcCtD
Mefloquine—Renal failure—Methotrexate—colon cancer	0.000257	0.00214	CcSEcCtD
Mefloquine—Ill-defined disorder—Capecitabine—colon cancer	0.000254	0.00212	CcSEcCtD
Mefloquine—Urticaria—Fluorouracil—colon cancer	0.000254	0.00212	CcSEcCtD
Mefloquine—Body temperature increased—Fluorouracil—colon cancer	0.000253	0.00211	CcSEcCtD
Mefloquine—Hypersensitivity—Vincristine—colon cancer	0.000253	0.0021	CcSEcCtD
Mefloquine—Sweating—Methotrexate—colon cancer	0.00025	0.00208	CcSEcCtD
Mefloquine—ABCB1—liver—colon cancer	0.000248	0.00261	CbGeAlD
Mefloquine—Malaise—Capecitabine—colon cancer	0.000247	0.00206	CcSEcCtD
Mefloquine—Hepatobiliary disease—Methotrexate—colon cancer	0.000247	0.00205	CcSEcCtD
Mefloquine—Vertigo—Capecitabine—colon cancer	0.000246	0.00205	CcSEcCtD
Mefloquine—Hypersensitivity—Irinotecan—colon cancer	0.000246	0.00205	CcSEcCtD
Mefloquine—Asthenia—Vincristine—colon cancer	0.000246	0.00205	CcSEcCtD
Mefloquine—Syncope—Capecitabine—colon cancer	0.000246	0.00205	CcSEcCtD
Mefloquine—Leukopenia—Capecitabine—colon cancer	0.000245	0.00204	CcSEcCtD
Mefloquine—Agranulocytosis—Methotrexate—colon cancer	0.000244	0.00203	CcSEcCtD
Mefloquine—Palpitations—Capecitabine—colon cancer	0.000242	0.00202	CcSEcCtD
Mefloquine—Loss of consciousness—Capecitabine—colon cancer	0.000241	0.002	CcSEcCtD
Mefloquine—Asthenia—Irinotecan—colon cancer	0.00024	0.002	CcSEcCtD
Mefloquine—Hypertension—Capecitabine—colon cancer	0.000237	0.00197	CcSEcCtD
Mefloquine—Hypersensitivity—Fluorouracil—colon cancer	0.000236	0.00196	CcSEcCtD
Mefloquine—Diarrhoea—Vincristine—colon cancer	0.000235	0.00195	CcSEcCtD
Mefloquine—Chest pain—Capecitabine—colon cancer	0.000233	0.00194	CcSEcCtD
Mefloquine—Myalgia—Capecitabine—colon cancer	0.000233	0.00194	CcSEcCtD
Mefloquine—Arthralgia—Capecitabine—colon cancer	0.000233	0.00194	CcSEcCtD
Mefloquine—Anxiety—Capecitabine—colon cancer	0.000232	0.00193	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000232	0.00193	CcSEcCtD
Mefloquine—Discomfort—Capecitabine—colon cancer	0.00023	0.00192	CcSEcCtD
Mefloquine—Diarrhoea—Irinotecan—colon cancer	0.000229	0.0019	CcSEcCtD
Mefloquine—Dizziness—Vincristine—colon cancer	0.000227	0.00189	CcSEcCtD
Mefloquine—Pruritus—Fluorouracil—colon cancer	0.000226	0.00188	CcSEcCtD
Mefloquine—Visual impairment—Methotrexate—colon cancer	0.000226	0.00188	CcSEcCtD
Mefloquine—Confusional state—Capecitabine—colon cancer	0.000225	0.00188	CcSEcCtD
Mefloquine—Oedema—Capecitabine—colon cancer	0.000224	0.00186	CcSEcCtD
Mefloquine—Erythema multiforme—Methotrexate—colon cancer	0.000222	0.00184	CcSEcCtD
Mefloquine—Dizziness—Irinotecan—colon cancer	0.000221	0.00184	CcSEcCtD
Mefloquine—Shock—Capecitabine—colon cancer	0.00022	0.00183	CcSEcCtD
Mefloquine—Nervous system disorder—Capecitabine—colon cancer	0.000219	0.00183	CcSEcCtD
Mefloquine—Eye disorder—Methotrexate—colon cancer	0.000219	0.00182	CcSEcCtD
Mefloquine—Diarrhoea—Fluorouracil—colon cancer	0.000219	0.00182	CcSEcCtD
Mefloquine—Thrombocytopenia—Capecitabine—colon cancer	0.000219	0.00182	CcSEcCtD
Mefloquine—Tinnitus—Methotrexate—colon cancer	0.000218	0.00182	CcSEcCtD
Mefloquine—Tachycardia—Capecitabine—colon cancer	0.000218	0.00182	CcSEcCtD
Mefloquine—Vomiting—Vincristine—colon cancer	0.000218	0.00182	CcSEcCtD
Mefloquine—Cardiac disorder—Methotrexate—colon cancer	0.000217	0.00181	CcSEcCtD
Mefloquine—Skin disorder—Capecitabine—colon cancer	0.000217	0.00181	CcSEcCtD
Mefloquine—Rash—Vincristine—colon cancer	0.000216	0.0018	CcSEcCtD
Mefloquine—Hyperhidrosis—Capecitabine—colon cancer	0.000216	0.0018	CcSEcCtD
Mefloquine—Dermatitis—Vincristine—colon cancer	0.000216	0.0018	CcSEcCtD
Mefloquine—Headache—Vincristine—colon cancer	0.000215	0.00179	CcSEcCtD
Mefloquine—Angiopathy—Methotrexate—colon cancer	0.000213	0.00177	CcSEcCtD
Mefloquine—Vomiting—Irinotecan—colon cancer	0.000212	0.00177	CcSEcCtD
Mefloquine—Dizziness—Fluorouracil—colon cancer	0.000212	0.00176	CcSEcCtD
Mefloquine—Mediastinal disorder—Methotrexate—colon cancer	0.000211	0.00176	CcSEcCtD
Mefloquine—Rash—Irinotecan—colon cancer	0.000211	0.00175	CcSEcCtD
Mefloquine—Dermatitis—Irinotecan—colon cancer	0.00021	0.00175	CcSEcCtD
Mefloquine—Chills—Methotrexate—colon cancer	0.00021	0.00175	CcSEcCtD
Mefloquine—Headache—Irinotecan—colon cancer	0.000209	0.00174	CcSEcCtD
Mefloquine—Hypotension—Capecitabine—colon cancer	0.000209	0.00174	CcSEcCtD
Mefloquine—Alopecia—Methotrexate—colon cancer	0.000207	0.00172	CcSEcCtD
Mefloquine—Mental disorder—Methotrexate—colon cancer	0.000205	0.00171	CcSEcCtD
Mefloquine—Erythema—Methotrexate—colon cancer	0.000204	0.0017	CcSEcCtD
Mefloquine—Malnutrition—Methotrexate—colon cancer	0.000204	0.0017	CcSEcCtD
Mefloquine—Nausea—Vincristine—colon cancer	0.000204	0.0017	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000204	0.0017	CcSEcCtD
Mefloquine—Vomiting—Fluorouracil—colon cancer	0.000203	0.00169	CcSEcCtD
Mefloquine—Insomnia—Capecitabine—colon cancer	0.000202	0.00168	CcSEcCtD
Mefloquine—Rash—Fluorouracil—colon cancer	0.000202	0.00168	CcSEcCtD
Mefloquine—Dermatitis—Fluorouracil—colon cancer	0.000202	0.00168	CcSEcCtD
Mefloquine—Paraesthesia—Capecitabine—colon cancer	0.000201	0.00167	CcSEcCtD
Mefloquine—Headache—Fluorouracil—colon cancer	0.0002	0.00167	CcSEcCtD
Mefloquine—Dyspnoea—Capecitabine—colon cancer	0.000199	0.00166	CcSEcCtD
Mefloquine—Nausea—Irinotecan—colon cancer	0.000198	0.00165	CcSEcCtD
Mefloquine—Dyspepsia—Capecitabine—colon cancer	0.000197	0.00164	CcSEcCtD
Mefloquine—Decreased appetite—Capecitabine—colon cancer	0.000194	0.00162	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000193	0.00161	CcSEcCtD
Mefloquine—Fatigue—Capecitabine—colon cancer	0.000193	0.0016	CcSEcCtD
Mefloquine—Vision blurred—Methotrexate—colon cancer	0.000192	0.0016	CcSEcCtD
Mefloquine—ABCB1—lymph node—colon cancer	0.00019	0.002	CbGeAlD
Mefloquine—Nausea—Fluorouracil—colon cancer	0.00019	0.00158	CcSEcCtD
Mefloquine—Ill-defined disorder—Methotrexate—colon cancer	0.000189	0.00158	CcSEcCtD
Mefloquine—Feeling abnormal—Capecitabine—colon cancer	0.000184	0.00153	CcSEcCtD
Mefloquine—Malaise—Methotrexate—colon cancer	0.000184	0.00153	CcSEcCtD
Mefloquine—Vertigo—Methotrexate—colon cancer	0.000183	0.00153	CcSEcCtD
Mefloquine—Gastrointestinal pain—Capecitabine—colon cancer	0.000183	0.00152	CcSEcCtD
Mefloquine—Leukopenia—Methotrexate—colon cancer	0.000183	0.00152	CcSEcCtD
Mefloquine—Urticaria—Capecitabine—colon cancer	0.000178	0.00148	CcSEcCtD
Mefloquine—Abdominal pain—Capecitabine—colon cancer	0.000177	0.00147	CcSEcCtD
Mefloquine—Body temperature increased—Capecitabine—colon cancer	0.000177	0.00147	CcSEcCtD
Mefloquine—Convulsion—Methotrexate—colon cancer	0.000177	0.00147	CcSEcCtD
Mefloquine—Arthralgia—Methotrexate—colon cancer	0.000174	0.00145	CcSEcCtD
Mefloquine—Myalgia—Methotrexate—colon cancer	0.000174	0.00145	CcSEcCtD
Mefloquine—Chest pain—Methotrexate—colon cancer	0.000174	0.00145	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000172	0.00144	CcSEcCtD
Mefloquine—Discomfort—Methotrexate—colon cancer	0.000172	0.00143	CcSEcCtD
Mefloquine—Confusional state—Methotrexate—colon cancer	0.000168	0.0014	CcSEcCtD
Mefloquine—Anaphylactic shock—Methotrexate—colon cancer	0.000166	0.00139	CcSEcCtD
Mefloquine—Hypersensitivity—Capecitabine—colon cancer	0.000165	0.00137	CcSEcCtD
Mefloquine—Nervous system disorder—Methotrexate—colon cancer	0.000163	0.00136	CcSEcCtD
Mefloquine—Thrombocytopenia—Methotrexate—colon cancer	0.000163	0.00136	CcSEcCtD
Mefloquine—Skin disorder—Methotrexate—colon cancer	0.000162	0.00135	CcSEcCtD
Mefloquine—Hyperhidrosis—Methotrexate—colon cancer	0.000161	0.00134	CcSEcCtD
Mefloquine—Asthenia—Capecitabine—colon cancer	0.00016	0.00134	CcSEcCtD
Mefloquine—Pruritus—Capecitabine—colon cancer	0.000158	0.00132	CcSEcCtD
Mefloquine—Hypotension—Methotrexate—colon cancer	0.000156	0.00129	CcSEcCtD
Mefloquine—Diarrhoea—Capecitabine—colon cancer	0.000153	0.00127	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000152	0.00126	CcSEcCtD
Mefloquine—Insomnia—Methotrexate—colon cancer	0.000151	0.00125	CcSEcCtD
Mefloquine—Paraesthesia—Methotrexate—colon cancer	0.000149	0.00124	CcSEcCtD
Mefloquine—Dyspnoea—Methotrexate—colon cancer	0.000148	0.00124	CcSEcCtD
Mefloquine—Somnolence—Methotrexate—colon cancer	0.000148	0.00123	CcSEcCtD
Mefloquine—Dizziness—Capecitabine—colon cancer	0.000148	0.00123	CcSEcCtD
Mefloquine—Dyspepsia—Methotrexate—colon cancer	0.000147	0.00122	CcSEcCtD
Mefloquine—Decreased appetite—Methotrexate—colon cancer	0.000145	0.0012	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000144	0.0012	CcSEcCtD
Mefloquine—Fatigue—Methotrexate—colon cancer	0.000143	0.00119	CcSEcCtD
Mefloquine—Vomiting—Capecitabine—colon cancer	0.000142	0.00118	CcSEcCtD
Mefloquine—Rash—Capecitabine—colon cancer	0.000141	0.00117	CcSEcCtD
Mefloquine—Dermatitis—Capecitabine—colon cancer	0.000141	0.00117	CcSEcCtD
Mefloquine—Headache—Capecitabine—colon cancer	0.00014	0.00117	CcSEcCtD
Mefloquine—Feeling abnormal—Methotrexate—colon cancer	0.000137	0.00114	CcSEcCtD
Mefloquine—Gastrointestinal pain—Methotrexate—colon cancer	0.000136	0.00113	CcSEcCtD
Mefloquine—Nausea—Capecitabine—colon cancer	0.000133	0.00111	CcSEcCtD
Mefloquine—Urticaria—Methotrexate—colon cancer	0.000132	0.0011	CcSEcCtD
Mefloquine—Abdominal pain—Methotrexate—colon cancer	0.000132	0.0011	CcSEcCtD
Mefloquine—Body temperature increased—Methotrexate—colon cancer	0.000132	0.0011	CcSEcCtD
Mefloquine—Hypersensitivity—Methotrexate—colon cancer	0.000123	0.00102	CcSEcCtD
Mefloquine—Asthenia—Methotrexate—colon cancer	0.000119	0.000994	CcSEcCtD
Mefloquine—Pruritus—Methotrexate—colon cancer	0.000118	0.00098	CcSEcCtD
Mefloquine—Diarrhoea—Methotrexate—colon cancer	0.000114	0.000948	CcSEcCtD
Mefloquine—Dizziness—Methotrexate—colon cancer	0.00011	0.000916	CcSEcCtD
Mefloquine—Vomiting—Methotrexate—colon cancer	0.000106	0.000881	CcSEcCtD
Mefloquine—Rash—Methotrexate—colon cancer	0.000105	0.000874	CcSEcCtD
Mefloquine—Dermatitis—Methotrexate—colon cancer	0.000105	0.000873	CcSEcCtD
Mefloquine—Headache—Methotrexate—colon cancer	0.000104	0.000868	CcSEcCtD
Mefloquine—Nausea—Methotrexate—colon cancer	9.89e-05	0.000823	CcSEcCtD
Mefloquine—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	5.77e-05	0.00477	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—PPARG—colon cancer	5.74e-05	0.00475	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CA7—colon cancer	5.66e-05	0.00468	CbGpPWpGaD
Mefloquine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	5.66e-05	0.00468	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—BAX—colon cancer	5.56e-05	0.0046	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CA7—colon cancer	5.49e-05	0.00455	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—DLC1—colon cancer	5.38e-05	0.00445	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	5.3e-05	0.00439	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	5.21e-05	0.00431	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—LGR5—colon cancer	5.06e-05	0.00419	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	5.02e-05	0.00415	CbGpPWpGaD
Mefloquine—ACHE—Peptide hormone metabolism—CTNNB1—colon cancer	4.96e-05	0.0041	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—ABCB1—colon cancer	4.91e-05	0.00406	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGFR3—colon cancer	4.91e-05	0.00406	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—TYMS—colon cancer	4.82e-05	0.00399	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—CDX2—colon cancer	4.76e-05	0.00394	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—PPARG—colon cancer	4.5e-05	0.00373	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—PPARG—colon cancer	4.43e-05	0.00367	CbGpPWpGaD
Mefloquine—BCHE—Peptide hormone metabolism—CTNNB1—colon cancer	4.43e-05	0.00366	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	4.39e-05	0.00363	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—CDX2—colon cancer	4.24e-05	0.00351	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—BRAF—colon cancer	4.23e-05	0.0035	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—DLC1—colon cancer	4.15e-05	0.00344	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—MUC2—colon cancer	4.04e-05	0.00335	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—BRAF—colon cancer	3.98e-05	0.0033	CbGpPWpGaD
Mefloquine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	3.94e-05	0.00326	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—LGR5—colon cancer	3.91e-05	0.00323	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—CDH1—colon cancer	3.9e-05	0.00323	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—APC—colon cancer	3.82e-05	0.00316	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—FGFR3—colon cancer	3.77e-05	0.00312	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—EP300—colon cancer	3.76e-05	0.00311	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CHST5—colon cancer	3.73e-05	0.00309	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ODC1—colon cancer	3.73e-05	0.00309	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	3.7e-05	0.00306	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AXIN2—colon cancer	3.63e-05	0.00301	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—MUC2—colon cancer	3.61e-05	0.00299	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—PTGS2—colon cancer	3.54e-05	0.00293	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—BRAF—colon cancer	3.46e-05	0.00286	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ODC1—colon cancer	3.43e-05	0.00284	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CHST5—colon cancer	3.43e-05	0.00284	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—PPARG—colon cancer	3.41e-05	0.00282	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CHST5—colon cancer	3.33e-05	0.00275	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ODC1—colon cancer	3.33e-05	0.00275	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—BRAF—colon cancer	3.26e-05	0.00269	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—BRAF—colon cancer	3.09e-05	0.00256	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1A—colon cancer	2.99e-05	0.00247	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—CASP3—colon cancer	2.99e-05	0.00247	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	2.96e-05	0.00245	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—EP300—colon cancer	2.95e-05	0.00244	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—CCND1—colon cancer	2.91e-05	0.00241	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	2.9e-05	0.0024	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—EP300—colon cancer	2.9e-05	0.0024	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	2.88e-05	0.00238	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AXIN2—colon cancer	2.81e-05	0.00232	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—SRC—colon cancer	2.77e-05	0.00229	CbGpPWpGaD
Mefloquine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	2.72e-05	0.00225	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	2.69e-05	0.00223	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—TP53—colon cancer	2.69e-05	0.00222	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—PTGS2—colon cancer	2.69e-05	0.00222	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CA7—colon cancer	2.68e-05	0.00222	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—EP300—colon cancer	2.68e-05	0.00221	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NRAS—colon cancer	2.66e-05	0.0022	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—BRAF—colon cancer	2.65e-05	0.00219	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	2.62e-05	0.00217	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	2.6e-05	0.00215	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	2.54e-05	0.0021	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	2.53e-05	0.0021	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CA7—colon cancer	2.53e-05	0.00209	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	2.46e-05	0.00203	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—CASP3—colon cancer	2.44e-05	0.00202	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—colon cancer	2.42e-05	0.00201	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	2.41e-05	0.002	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—CASP3—colon cancer	2.38e-05	0.00197	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—BRAF—colon cancer	2.37e-05	0.00196	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	2.35e-05	0.00194	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—MYC—colon cancer	2.33e-05	0.00193	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	2.33e-05	0.00193	CbGpPWpGaD
Mefloquine—ACHE—Phospholipid metabolism—PIK3CA—colon cancer	2.32e-05	0.00192	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—CDKN1A—colon cancer	2.3e-05	0.0019	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—colon cancer	2.29e-05	0.00189	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	2.29e-05	0.00189	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—EGFR—colon cancer	2.28e-05	0.00189	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	2.27e-05	0.00188	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—EP300—colon cancer	2.23e-05	0.00185	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	2.18e-05	0.00181	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—PIK3CA—colon cancer	2.18e-05	0.0018	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—KRAS—colon cancer	2.16e-05	0.00178	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—SRC—colon cancer	2.13e-05	0.00176	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—colon cancer	2.1e-05	0.00174	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	2.1e-05	0.00174	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	2.1e-05	0.00174	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—TP53—colon cancer	2.08e-05	0.00172	CbGpPWpGaD
Mefloquine—BCHE—Phospholipid metabolism—PIK3CA—colon cancer	2.07e-05	0.00171	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	2.06e-05	0.0017	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—NRAS—colon cancer	2.05e-05	0.00169	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—VEGFA—colon cancer	2.02e-05	0.00167	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—colon cancer	1.95e-05	0.00161	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.94e-05	0.00161	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—TP53—colon cancer	1.92e-05	0.00158	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—EGFR—colon cancer	1.86e-05	0.00154	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TGFB1—colon cancer	1.85e-05	0.00153	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.79e-05	0.00148	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—AKT1—colon cancer	1.78e-05	0.00147	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—KRAS—colon cancer	1.76e-05	0.00146	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.73e-05	0.00143	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—colon cancer	1.72e-05	0.00142	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.66e-05	0.00138	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—PIK3CA—colon cancer	1.65e-05	0.00137	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CA7—colon cancer	1.65e-05	0.00137	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ODC1—colon cancer	1.62e-05	0.00134	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CHST5—colon cancer	1.62e-05	0.00134	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—PIK3CA—colon cancer	1.62e-05	0.00134	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—AKT1—colon cancer	1.62e-05	0.00134	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—HRAS—colon cancer	1.59e-05	0.00132	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.54e-05	0.00127	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ODC1—colon cancer	1.53e-05	0.00127	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CHST5—colon cancer	1.53e-05	0.00127	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—HRAS—colon cancer	1.5e-05	0.00124	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.49e-05	0.00123	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.46e-05	0.00121	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—HRAS—colon cancer	1.42e-05	0.00117	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.42e-05	0.00117	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.37e-05	0.00114	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—AKT1—colon cancer	1.35e-05	0.00112	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—AKT1—colon cancer	1.32e-05	0.00109	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.26e-05	0.00104	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—HRAS—colon cancer	1.22e-05	0.00101	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.21e-05	0.001	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.17e-05	0.00097	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.14e-05	0.000944	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.13e-05	0.000935	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.11e-05	0.000921	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.1e-05	0.000913	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—HRAS—colon cancer	1.09e-05	0.0009	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.08e-05	0.000894	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.05e-05	0.000869	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—FGFR3—colon cancer	1.05e-05	0.000868	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.02e-05	0.000845	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.01e-05	0.000834	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ODC1—colon cancer	1e-05	0.000828	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CHST5—colon cancer	1e-05	0.000828	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	9.95e-06	0.000823	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ABCB1—colon cancer	9.86e-06	0.000816	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—TYMS—colon cancer	9.68e-06	0.000801	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—APC—colon cancer	9.64e-06	0.000797	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—NRAS—colon cancer	9.64e-06	0.000797	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—CTNNB1—colon cancer	9.37e-06	0.000775	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	9.26e-06	0.000766	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	9.15e-06	0.000757	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	9.13e-06	0.000755	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ABCB1—colon cancer	9.06e-06	0.00075	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—BRAF—colon cancer	9.06e-06	0.000749	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.99e-06	0.000744	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	8.95e-06	0.000741	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—TYMS—colon cancer	8.9e-06	0.000736	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ABCB1—colon cancer	8.8e-06	0.000728	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—EGFR—colon cancer	8.78e-06	0.000726	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—TYMS—colon cancer	8.64e-06	0.000715	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	8.46e-06	0.0007	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—PIK3CA—colon cancer	8.39e-06	0.000694	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—CTNNB1—colon cancer	8.36e-06	0.000691	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—KRAS—colon cancer	8.29e-06	0.000686	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FGFR3—colon cancer	8.1e-06	0.00067	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	7.77e-06	0.000643	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—PIK3CA—colon cancer	7.62e-06	0.00063	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	7.52e-06	0.000622	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.46e-06	0.000617	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—APC—colon cancer	7.44e-06	0.000616	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—NRAS—colon cancer	7.44e-06	0.000616	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—HRAS—colon cancer	7.05e-06	0.000583	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—BRAF—colon cancer	6.99e-06	0.000579	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PPARG—colon cancer	6.86e-06	0.000567	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—AKT1—colon cancer	6.86e-06	0.000567	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.85e-06	0.000567	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CASP3—colon cancer	6.79e-06	0.000562	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—EGFR—colon cancer	6.78e-06	0.000561	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.65e-06	0.00055	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCND1—colon cancer	6.61e-06	0.000547	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CTNNB1—colon cancer	6.55e-06	0.000542	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—PIK3CA—colon cancer	6.48e-06	0.000536	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—KRAS—colon cancer	6.4e-06	0.00053	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CDKN1A—colon cancer	6.4e-06	0.000529	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	6.35e-06	0.000525	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PPARG—colon cancer	6.3e-06	0.000521	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—AKT1—colon cancer	6.23e-06	0.000515	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PPARG—colon cancer	6.12e-06	0.000506	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EP300—colon cancer	6.09e-06	0.000503	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SRC—colon cancer	5.92e-06	0.00049	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PIK3CA—colon cancer	5.88e-06	0.000487	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—VEGFA—colon cancer	5.76e-06	0.000477	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NRAS—colon cancer	5.69e-06	0.000471	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HRAS—colon cancer	5.44e-06	0.00045	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PTGS2—colon cancer	5.4e-06	0.000446	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MYC—colon cancer	5.3e-06	0.000439	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—AKT1—colon cancer	5.29e-06	0.000438	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TGFB1—colon cancer	5.29e-06	0.000438	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CASP3—colon cancer	5.24e-06	0.000434	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EGFR—colon cancer	5.19e-06	0.000429	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCND1—colon cancer	5.1e-06	0.000422	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CTNNB1—colon cancer	5.06e-06	0.000418	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PTGS2—colon cancer	4.96e-06	0.00041	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CDKN1A—colon cancer	4.94e-06	0.000408	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—KRAS—colon cancer	4.9e-06	0.000405	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PTGS2—colon cancer	4.81e-06	0.000398	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—AKT1—colon cancer	4.81e-06	0.000398	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EP300—colon cancer	4.7e-06	0.000389	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SRC—colon cancer	4.57e-06	0.000378	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PIK3CA—colon cancer	4.5e-06	0.000372	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—EP300—colon cancer	4.49e-06	0.000371	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—VEGFA—colon cancer	4.45e-06	0.000368	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NRAS—colon cancer	4.4e-06	0.000364	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TP53—colon cancer	4.36e-06	0.00036	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—TYMS—colon cancer	4.22e-06	0.000349	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HRAS—colon cancer	4.17e-06	0.000345	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—EP300—colon cancer	4.12e-06	0.000341	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MYC—colon cancer	4.09e-06	0.000339	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TGFB1—colon cancer	4.08e-06	0.000338	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ABCB1—colon cancer	4.04e-06	0.000335	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EGFR—colon cancer	4e-06	0.000331	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—EP300—colon cancer	4e-06	0.000331	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—TYMS—colon cancer	3.97e-06	0.000329	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—KRAS—colon cancer	3.78e-06	0.000313	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AKT1—colon cancer	3.68e-06	0.000304	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PIK3CA—colon cancer	3.48e-06	0.000288	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TP53—colon cancer	3.36e-06	0.000278	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3CA—colon cancer	3.32e-06	0.000275	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HRAS—colon cancer	3.22e-06	0.000266	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3CA—colon cancer	3.05e-06	0.000252	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PPARG—colon cancer	2.99e-06	0.000247	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3CA—colon cancer	2.96e-06	0.000245	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AKT1—colon cancer	2.84e-06	0.000235	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PPARG—colon cancer	2.81e-06	0.000233	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—AKT1—colon cancer	2.71e-06	0.000224	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ABCB1—colon cancer	2.64e-06	0.000219	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—TYMS—colon cancer	2.6e-06	0.000215	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AKT1—colon cancer	2.49e-06	0.000206	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AKT1—colon cancer	2.42e-06	0.0002	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PTGS2—colon cancer	2.35e-06	0.000194	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PTGS2—colon cancer	2.21e-06	0.000183	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—EP300—colon cancer	1.95e-06	0.000162	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—EP300—colon cancer	1.84e-06	0.000152	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PPARG—colon cancer	1.84e-06	0.000152	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PTGS2—colon cancer	1.45e-06	0.00012	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3CA—colon cancer	1.45e-06	0.00012	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3CA—colon cancer	1.36e-06	0.000113	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—EP300—colon cancer	1.2e-06	9.96e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AKT1—colon cancer	1.18e-06	9.77e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AKT1—colon cancer	1.11e-06	9.2e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3CA—colon cancer	8.9e-07	7.37e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AKT1—colon cancer	7.27e-07	6.02e-05	CbGpPWpGaD
